Panagiotis Baxevanos
Panagiotis Baxevanos publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, on topics such as Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies and Lung Cancer Treatments and Mutations.
- World rank
- #3,215,942 of 7,710,434 ranked researchers
- Rank in Greece
- #14,352 of 33,280
- Works
- 22
- Citations
- 404
- Citations per work
- 18.4
What does Panagiotis Baxevanos research?
Panagiotis Baxevanos's work is mostly in Medicine (79%), Health Professions (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1882.6%
- Medicine1779.4%
- Health Professions13.2%
- Everything else417.4%
- 1Oncology40% of their works
- 2Pulmonary and Respiratory Medicine25% of their works
- 3Radiology, Nuclear Medicine and Imaging6% of their works
- 4Surgery5% of their works
- 5General Health Professions3% of their works
- 6Epidemiology3% of their works
Research topics
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Inflammatory Biomarkers in Disease Prognosis
- Neuroendocrine Tumor Research Advances
- Pancreatic and Hepatic Oncology Research
- Radiomics and Machine Learning in Medical Imaging
Which keywords describe Panagiotis Baxevanos's research?
The keywords of their largest research topics: Tumor Microenvironment, Chemotherapy, Clinical Trials, Targeted Therapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Metastasis and Immunotherapy.
- Surgical Complications
- Pancreatic Neuroendocrine Tumors
- Neuroendocrine Tumors
- Inflammation
- Lung Cancer
- Small-Cell Lung Cancer
- EGFR Mutations
- Immunotherapy
- PD-1 and PD-L1
- Targeted Therapy
- Chemotherapy
- Tumor Microenvironment
- Clinical Trials
- Immune Checkpoint Blockade
- Metastasis
- ALK Inhibitors
- Genomic Profiles
- CT Screening
- Cancer
- Medical Imaging
- Pancreatic Cancer
- Radiomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Tumor Microenvironment163 topics
- Chemotherapy143 topics
- Clinical Trials142 topics
- Targeted Therapy142 topics
- Immune Checkpoint Blockade111 topic
- PD-1 and PD-L1111 topic
- Metastasis102 topics
- Immunotherapy92 topics
- ALK Inhibitors71 topic
- EGFR Mutations71 topic
- Genomic Profiles71 topic
- Small-Cell Lung Cancer71 topic
- CT Screening51 topic
- Lung Cancer51 topic
- Cancer31 topic
- Inflammation31 topic
- Medical Imaging21 topic
- Neuroendocrine Tumors21 topic
- Pancreatic Cancer21 topic
- Pancreatic Neuroendocrine Tumors21 topic
- Radiomics21 topic
- Surgical Complications21 topic
Where does Panagiotis Baxevanos work?
Panagiotis Baxevanos's main affiliation in the publication record is NIMTS Hospital, Greece.
How many publications and citations does Panagiotis Baxevanos have?
OpenAlex counts 22 works and 404 citations for Panagiotis Baxevanos, an h-index of 9, ranking #3,215,942 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Panagiotis Baxevanos. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.